InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by GOTTSCHALK ADRIAN, Chief Executive Officer. Director active across 1 companies, notably Foghorn Therapeutics Inc.. Cumulatively, 2 filings have been published. The latest transaction was disclosed on 20 August 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€10,63723,000 shares@ €0.4625100.0% of flow
Common Stock
SEC:0001562180-21-005521·
€10,63723,000 shares@ €0.46250.0035% mcap50.0% of flow
Common Stock
SEC:0001562180-21-005521:0·
2 of 2 declarations
About GOTTSCHALK ADRIAN
Adrian Gottschalk is the Chief Executive Officer of Foghorn Therapeutics Inc. He oversees the company's operations and is responsible for implementing the business strategy. Adrian plays a crucial role in leading the company and making strategic decisions. His leadership is essential for ensuring Foghorn's growth and success.
